These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 14756558

  • 1. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF, Yang J, Eigenbrot C, Moran P, Peek M, Lipari MT, Kirchhofer D.
    Biochemistry; 2004 Feb 10; 43(5):1223-9. PubMed ID: 14756558
    [Abstract] [Full Text] [Related]

  • 2. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
    Dickinson CD, Shobe J, Ruf W.
    J Mol Biol; 1998 Apr 10; 277(4):959-71. PubMed ID: 9545384
    [Abstract] [Full Text] [Related]

  • 3. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
    Huang H, Norledge BV, Liu C, Olson AJ, Edgington TS.
    Biochemistry; 2003 Sep 16; 42(36):10619-26. PubMed ID: 12962485
    [Abstract] [Full Text] [Related]

  • 4. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J, Perera L, Stafford D, Pedersen L.
    J Mol Biol; 2001 Apr 13; 307(5):1503-17. PubMed ID: 11292356
    [Abstract] [Full Text] [Related]

  • 5. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W, Shobe J, Rao SM, Dickinson CD, Olson A, Edgington TS.
    Biochemistry; 1999 Feb 16; 38(7):1957-66. PubMed ID: 10026279
    [Abstract] [Full Text] [Related]

  • 6. Large enhancement of functional activity of active site-inhibited factor VIIa due to protein dimerization: insights into mechanism of assembly/disassembly from tissue factor.
    Stone MD, Harvey SB, Martinez MB, Bach RR, Nelsestuen GL.
    Biochemistry; 2005 Apr 26; 44(16):6321-30. PubMed ID: 15835921
    [Abstract] [Full Text] [Related]

  • 7. Solution structure of the N-terminal EGF-like domain from human factor VII.
    Muranyi A, Finn BE, Gippert GP, Forsén S, Stenflo J, Drakenberg T.
    Biochemistry; 1998 Jul 28; 37(30):10605-15. PubMed ID: 9692950
    [Abstract] [Full Text] [Related]

  • 8. Sequential coagulation factor VIIa domain binding to tissue factor.
    Osterlund M, Persson E, Carlsson U, Freskgård PO, Svensson M.
    Biochem Biophys Res Commun; 2005 Dec 02; 337(4):1276-82. PubMed ID: 16236263
    [Abstract] [Full Text] [Related]

  • 9. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
    Carlsson K, Persson E, Carlsson U, Svensson M.
    Biochem Biophys Res Commun; 2006 Oct 27; 349(3):1111-6. PubMed ID: 16970919
    [Abstract] [Full Text] [Related]

  • 10. Predicted solution structure of zymogen human coagulation FVII.
    Perera L, Darden TA, Pedersen LG.
    J Comput Chem; 2002 Jan 15; 23(1):35-47. PubMed ID: 11913388
    [Abstract] [Full Text] [Related]

  • 11. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E, Olsen OH.
    FEBS J; 2009 Jun 15; 276(11):3099-109. PubMed ID: 19490111
    [Abstract] [Full Text] [Related]

  • 12. Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.
    Chang YJ, Hamaguchi N, Chang SC, Ruf W, Shen MC, Lin SW.
    Biochemistry; 1999 Aug 24; 38(34):10940-8. PubMed ID: 10460149
    [Abstract] [Full Text] [Related]

  • 13. Cellular immune and cytokine pathways resulting in tissue factor expression and relevance to septic shock.
    Edgington TS, Mackman N, Fan ST, Ruf W.
    Nouv Rev Fr Hematol (1978); 1992 Aug 24; 34 Suppl():S15-27. PubMed ID: 1364116
    [Abstract] [Full Text] [Related]

  • 14. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
    Kemball-Cook G, Johnson DJ, Tuddenham EG, Harlos K.
    J Struct Biol; 1999 Oct 24; 127(3):213-23. PubMed ID: 10544046
    [Abstract] [Full Text] [Related]

  • 15. Transition state analysis of the complex between coagulation factor VIIa and tissue factor: suggesting a sequential domain-binding pathway.
    Osterlund M, Persson E, Svensson M, Carlsson U, Freskgård PO.
    Biochem Biophys Res Commun; 2005 Feb 18; 327(3):789-93. PubMed ID: 15649415
    [Abstract] [Full Text] [Related]

  • 16. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV, Petrovan RJ, Ruf W, Olson AJ.
    Proteins; 2003 Nov 15; 53(3):640-8. PubMed ID: 14579355
    [Abstract] [Full Text] [Related]

  • 17. Factor VIIa's first epidermal growth factor-like domain's role in catalytic activity.
    Jin J, Chang J, Chang JY, Kelley RF, Stafford DW, Straight DL.
    Biochemistry; 1999 Jan 26; 38(4):1185-92. PubMed ID: 9930978
    [Abstract] [Full Text] [Related]

  • 18. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
    Edgington TS, Dickinson CD, Ruf W.
    Thromb Haemost; 1997 Jul 26; 78(1):401-5. PubMed ID: 9198187
    [Abstract] [Full Text] [Related]

  • 19. Dimerization of tissue factor supports solution-phase autoactivation of factor VII without influencing proteolytic activation of factor X.
    Doñate F, Kelly CR, Ruf W, Edgington TS.
    Biochemistry; 2000 Sep 19; 39(37):11467-76. PubMed ID: 10985793
    [Abstract] [Full Text] [Related]

  • 20. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
    Ashton AW, Boehm MK, Johnson DJ, Kemball-Cook G, Perkins SJ.
    Biochemistry; 1998 Jun 02; 37(22):8208-17. PubMed ID: 9609717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.